Bicara Therapeutics INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Bicara Therapeutics Inc. announced its 2026 Annual Meeting of Stockholders will be held virtually on June 9, 2026, to elect directors and ratify auditor appointment.
NASDAQ
DEFA14A: Bicara Therapeutics Sets Date for 2025 Annual Meeting, Outlines Key Proposals for Stockholder Vote
Bicara Therapeutics has scheduled its annual stockholder meeting for June 9, 2025, featuring proposals for director elections and auditor ratification.
NASDAQ
Bicara Therapeutics will hold its 2025 Annual Meeting of Stockholders virtually on June 9, 2025, to elect directors and ratify the appointment of KPMG LLP as its independent accounting firm.